¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ICOMP newsletter on management of population programmes."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population
    1. Àα¸ 2. ¸ðÁý´Ü, Áý´Ü
  • population attributable risk
    ¸ðÁý´Ü±âÀÎÀ§Çèµµ
  • population density
    Àα¸¹Ðµµ
  • population dynamics
    Àα¸µ¿ÅÂ
  • population equivalent
    Àα¸ÇØ´ç·®
  • population excess rate
    ¸ðÁý´ÜÃʰúÀ²
  • population genetics
    Áý´ÜÀ¯ÀüÇÐ
  • population mean
    ¸ðÁý´ÜÆò±Õ
  • population medicine
    Àα¸ÀÇÇÐ
  • population mutation
    Áý´Üµ¹¿¬º¯ÀÌ
  • population policy
    Àα¸Á¤Ã¥
  • population pyramid
    Àα¸¸ðÇü, Àα¸ÇǶó¹Ìµå
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼
  • population variance
    ¸ðÁý´ÜºÐ»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population genetics
    Áý´ÜÀ¯ÀüÇÐ
  • infinite population
    ¹«ÇѸðÁý´Ü
  • island population
    °í¸³Àα¸Áý´Ü
  • model population
    ¸ðÇüÀα¸
  • national population mortality
    ±¹¹Î»ç¸Á·ü
  • population mean
    ¸ðÆò±Õ
  • population medicine
    Àα¸ÀÇÇÐ
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ
  • natural population
    ÀÚ¿¬Áý´Ü, ÀÚ¿¬°³Ã¼±º
  • population
    Àα¸, ¸ðÁý´Ü
  • population policy
    Àα¸Á¤Ã¥
  • population pyramid
    Àα¸¸ðÇü, Àα¸ÇǶó¹Ìµå
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼
  • population variance
    ¸ðÁý´ÜºÐ»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ(¡­ÔÍæÔܨì¶).
  • population policy
    Àα¸Á¤Ã¥(ÊÙËøÌ¤).
  • population problem
    Àα¸¹®Á¦.
  • population pyramid
    Àα¸¸ðÇü(ËöË´ËÎÌ´).
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼(ÊÙ̧ËÛ).
  • population variance
    ¸ðºÐ»ê(ËÎËÓË×).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • total quality management
    Á¾ÇÕÀû Áú°ü¸®.
  • asynchronous population
    ºñµ¿Á¶(¼¼Æ÷)Áý´Ü
  • bacterial population
    ¼¼±ÕÁý´Ü
  • composition of population
    Àα¸±¸¼º(ËöË´ Ë´ËÛ).
  • infinite population
    ¹«ÇѸðÁý´Ü.
  • midyear population
    ¿¬¾ÓÀα¸(ËçËâËöË´).
  • model population
    ¸ðÇüÀα¸(ËÎÌ´ËöË´).
  • movement of population
    Àα¸À̵¿(ËöË´ ËöËÄ).
  • national population mortality
    ±¹¹Î»ç¸Á·ü(~Ë×ËÎËô).
  • natural population
    ÀÚ¿¬Áý´Ü(~̤ËÀ), ÀÚ¿¬°³Ã¼±º(~˧̧˴).
  • population
    Àα¸, ¸ðÁý´Ü(ËÎ̤ËÀ) Åë°èÀÇ , Áý´Ü, °³Ã¼±º(˧̧˴).
  • population density
    Àα¸¹Ðµµ(ÊÙËÑ̬).
  • population dynamics
    Áý´Üµ¿ÅÂ, Àα¸µ¿·ÂÇÐ(ÊÙËÄËç̰).
  • population equivalent
    Àα¸´ç·®(ÊÙËÀËâ).
  • population genetics
    Áý´ÜÀ¯ÀüÇÐ(ÊÙËôËøÌ°).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CPDL cumulative population doubling level
CPK cell population kinetic [model]; creatine phosphokinase
CPS carbamoylphosphate synthetase; cardioplegic perfusion solution; centipoise; cervical pain syndrome; ...
GCP geriatric cancer population; granulocyte chemotactic protein
HARP homeless and at-risk population
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PD Population doublings
pEPSP population excitatory postsynaptic potential
PS Population spike
PSA Population spike amplitude
PAF Population-attributable fractions
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pharmacologic management
    ¾à¹° Ä¡·á, ¾à¹° ¿ä¹ý
  • postoperative management
    ¼ö¼úÈÄ °ü¸®, ¼úÈÄ °ü¸®¹ý
  • postoprative management
    ¼ö¼ú ÈÄ °ü¸®
  • postsurgical management
    ¼ö¼úÈÄ °ü¸®
  • risk management
    ¼úÀÚÀÇ ¾ÈÀü ¼öÄ¢
  • space management
    °ø°£ °ü¸®
  • ward management
    º´½Ç °ü¸®, º´µ¿ °ü¸®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
synchronous cell population <cell culture> A culture of cells that all divide in synchrony.
Particularly useful for certain studies of the cell cycle, cells can be made synchronous by depriving them of essential molecules, which are then restored. Synchronisation breaks down after a few cycles, however, as individual cells have unique division rates.
(19 Jan 1998)
q in population genetics The frequency of the less common of two different alternative (allelic) versions of a gene. (the frequency of the more common allele is p).
(12 Dec 1998)
topotypical population <zoology> Population occurring at the type locality from which the type specimen was taken.
(09 Jan 1998)
urban population The inhabitants of a city or town, including metropolitan areas and suburban areas.
(12 Dec 1998)
adaptive management A continuing process of action-based planning, monitoring, researching, evaluating, and adjusting with the objective of improving implementation and achieving the goals of the selected alternative.
(05 Dec 1998)
adaptive management area Landscape units designated for development and testing of technical and social approaches to achieving desired ecological, economic, and other social objectives.
(05 Dec 1998)
management activities Planned activities initiated by land managers to meet the desired future condition for an area. Management activities may include thinning, timber harvest, prescribed burning, tree planting, and other activities.
(05 Dec 1998)
management area Management areas are specific geographical areas defined by a forest plan. Each management area has a set of objectives and a management prescription unique to it.
(05 Dec 1998)
management audit Management review designed to evaluate efficiency and to identify areas in need of management improvement within the institution in order to ensure effectiveness in meeting organizational goals.
(12 Dec 1998)
management indicator species A species whose habitat requirements most reflect those of the species community in the habitat of concern, usually used to indicate habitat quality and to predict future conditions.
(09 Oct 1997)
management information systems Systems designed to provide information primarily concerned with the administrative functions associated with the provision and utilization of services; also includes program planning, etc.
(12 Dec 1998)
management plan A plan guiding overall management of an area administered by a federal or state agency. A management plan usually includes objectives, goals, standards and guidelines, management actions, and monitoring plans.
(05 Dec 1998)
management quality circles Participation of employees with management as a labour-management team, in decisions pertaining to the operational activities of the organization or industry.
(12 Dec 1998)
case management A traditional term for all the activities which a physician or other health care professional normally performs to insure the coordination of the medical services required by a patient. It also, when used in connection with managed care, covers all the activities of evaluating the patient, planning treatment, referral, and follow-up so that care is continuous and comprehensive and payment for the care is obtained.
(12 Dec 1998)
materials management, hospital The management of all procurement, distribution, and storage of equipment and supplies, as well as logistics management including laundry, processing of reusables, etc.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • management accounting
    ¿ø°¡ °è»ê
  • management engineering
    °æ¿µ(°ü¸®)°øÇÐ
  • management information system
    °æ¿µ Á¤º¸ ½Ã½ºÅÛ
  • management science
    °æ¿µ °úÇÐ;°ü¸® °øÇÐ
  • management shares
    (ÁÖ·Î ¿µ)ÀÓ¿øÁÖ
  • management training exercise
    °æ¿µÀÚ ÈÆ·Ã
  • management training program
    °ü¸®ÀÚ ÈÆ·Ã °èȹ
  • matrix management
    ¸ÅÆ®¸¯½º ¸Å´ÏÁö¸ÕÆ®(Àü¹® ½ºÅÂÇÁ¸¦ ÇöÁöÀÇ ÀÏ»ó ¾÷¹« Á¶¾ðÀÚ°â Áß¾Ó ½ºÅÂÇÁ°¡ µÇ°Ô ÇÏ´Â Á¶Á÷ ÇüÅÂ
  • middle management
    Áß°£ °ü¸®ÀÚÃþ 9
  • top management
    (±â¾÷ÀÇ) ÃÖ°í°æ¿µ °ü¸®Á¶Á÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á